Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review

被引：8

作者：

Taxonera, Carlos ^{[1
]}

Alba, Cristina ^{[1
]}

Colmenares, Michel ^{[1
]}

Olivares, David ^{[1
]}

Rey, Enrique ^{[1
]}

机构：

[1] Inst Invest Hosp Clin San Carlos IdISSC, Gastroenterol, Inflammatory Bowel Dis Unit, Hosp Clin San Carlo, Madrid, Spain

来源：

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2020年 / 13卷

关键词：

adalimumab; Crohn's disease; granulomatous cheilitis; infliximab; orofacial granulomatosis; ustekinumab; vedolizumab; MELKERSSON-ROSENTHAL-SYNDROME; OROFACIAL GRANULOMATOSIS; INFLIXIMAB; THERAPY; MANIFESTATIONS; CHILDREN;

D O I：

10.1177/1756284820934327

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Granulomatous cheilitis, characterized by persistent inflammation of the lips and a granulomatous histology, is sometimes associated with Crohn's disease and is a therapeutic challenge. Reported evidence indicates treatment with an anti-TNF agent (mainly infliximab) is the most recommended therapeutic option after failure of conventional treatments. The clinical case reported the effectiveness of ustekinumab, a monoclonal antibody against interleukins 12/23, to induce the remission of severe and recurrent granulomatous cheilitis in a patient with Crohn's disease.

引用

页数：6

共 50 条

[21] Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn’s disease
Hoekman D.R.
Roelofs J.J.T.H.
van Schuppen J.
Schonenberg-Meinema D.
D’Haens G.R.
Benninga M.A.
Clinical Journal of Gastroenterology, 2016, 9 (2) : 73 - 78
[22] Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn's disease
Tu, Tong
Chen, Mengqi
Li, Manying
Liu, Linxin
Chen, Zihan
Lin, Jianming
Chen, Baili
He, Yao
Chen, Minhu
Zeng, Zhirong
Zhuang, Xiaojun
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
[23] Metastatic Vulvar Crohn's Disease-A Rare Case Report and Short Review of Literature
Das, Debajit
Gupta, Bhaskar
Saha, Mahimanjan
INDIAN JOURNAL OF DERMATOLOGY, 2016, 61 (01) : 70 - 74
[24] Granulomatous hepatitis with Crohn's disease: a case report
Suzuki, Tatsuya
Hayakawa, Yuka
Kaneko, Shun
Takenaka, Kento
Watakabe, Keiya
Kinowaki, Yuko
Takemoto, Akira
Ohtsuka, Kazuo
Asahina, Yasuhiro
Okamoto, Ryuichi
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (03) : 551 - 556
[25] Severe Refractory Orofacial Crohn's Disease: Report of a Case
Quezada, Sandra
Turner, Patricia L.
Alexiev, Borislav
Daly, Barry
Cross, Raymond
DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (10) : 2290 - 2295
[26] Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
Grillo, Thais Gagno
Almeida, Luciana Rocha
Beraldo, Rodrigo Fedatto
Marcondes, Mariana Barros
Rios Queiroz, Diego Aparecido
da Silva, Daniel Luiz
Quera, Rodrigo
Baima, Julio Pinheiro
Saad-Hossne, Rogerio
Sassaki, Ligia Yukie
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (33) : 10382 - 10391
[27] Ustekinumab Successfully Treats and Maintains Remission of Pyostomatitis Vegetans Associated with Crohn's Disease
Doumeth, Sarah Abi
Abbas, Ossama
Hashash, Jana G.
CROHNS & COLITIS 360, 2020, 2 (01)
[28] Metastatic cutaneous Crohn's disease of the face: a case report and review of the literature
Albuquerque, Andreia
Magro, Fernando
Rodrigues, Susana
Lopes, Joanne
Lopes, Susana
Dias, Jose Macedo
Carneiro, Fatima
Macedo, Guilherme
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (10) : 954 - 956
[29] Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: Case series and literature review
Hofmann, Adam
Beaulieu, Yanick
Bernard, Francis
Rico, Philippe
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2009, 23 (12): : 829 - 833
[30] Favorable response to composite treatment including infliximab in a case of granulomatous cheilitis with Crohn's disease
Koga, Monji
Koga, Kaori
Tatsukawa, Ryoko
Imafuku, Shinichi
JOURNAL OF DERMATOLOGY, 2015, 42 (06) : 651 - 652

← 1 2 3 4 5 →